Rezolute (RZLT) Interest Coverage Ratio (2012 - 2019)
Rezolute's (RZLT) quarterly Interest Coverage Ratio came in at 0.74 in Q2 2019, up 95.84% year-on-year from 0.38 in Q2 2018, and up 74.34% quarter-over-quarter from 2.89 in Q1 2019.
Rezolute (RZLT) Interest Coverage Ratio (2012 - 2019) Analysis & Trends
Rezolute has disclosed Interest Coverage Ratio across 8 years of filings, most recently posting 0.74 for Q2 2019.
- Interest Coverage Ratio for Q2 2019 came in at 0.74, up 95.84% year-over-year; the trailing twelve-month figure through Mar 2020 was 4.69 (down 20.21% YoY), and the FY2021 annual result was 61.05, changed N/A from the prior year.
- Interest Coverage Ratio came in at 0.74 for Q2 2019 at Rezolute, up from 2.89 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.74 in Q2 2019 to a low of 39122.16 in Q4 2017.
- The 5-year median for Interest Coverage Ratio is 1390.15 (2015), against an average of 4067.51.
- Across the five-year window, Interest Coverage Ratio slumped 237763.95% in 2015 and jumped 99.99% in 2018, its largest moves.
- Rezolute's Interest Coverage Ratio stood at 2948.9 in 2015, then advanced by 18.71% to 2397.29 in 2016, then plunged by 1531.93% to 39122.16 in 2017, then soared by 99.99% to 2.45 in 2018, then surged by 69.81% to 0.74 in 2019.
- The last three Interest Coverage Ratio figures came in at 0.74 (Q2 2019), 2.89 (Q1 2019), and 2.45 (Q4 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -0.74 |
| Mar 31, 2019 | -2.89 |
| Dec 31, 2018 | -2.45 |
| Sep 30, 2018 | -2.81 |
| Jun 30, 2018 | -17.80 |
| Mar 31, 2018 | -92.83 |
| Dec 31, 2017 | -39,122.16 |
| Sep 30, 2016 | -2,397.29 |
| Jun 30, 2016 | -4,280.62 |
| Mar 31, 2016 | -3,250.63 |
| Dec 31, 2015 | -2,948.90 |
| Sep 30, 2015 | -2,045.69 |
| Jun 30, 2015 | -1,677.62 |
| Mar 31, 2015 | -1,102.68 |
| Dec 31, 2014 | -1,334.94 |
| Sep 30, 2014 | -4,470.24 |
| Jun 30, 2014 | -4,459.43 |
| Mar 31, 2014 | -0.46 |
| Dec 31, 2013 | -1.04 |
| Sep 30, 2013 | -4.25 |